Abstrakt

Aim: Sudden sensorineural hearing loss (SSNHL) involves acute unexplained hearing loss, nearly always one-sided of 30dB or greater over at least three contiguous audiometric frequencies. The aetiology of SSNHL is mostly unknown. According to the literature, the causes include vascular, microbial and autoimmune problems. There is still no agreed standard treatment. The aim of the paper was to evaluate the results of combined pharmacotherapy and hyperbaric oxygen therapy in patients with idiopathic sudden deafness. Material/Methods: The study was carried out on 40 patients with SSNHL. The patients were divided into two groups: group I – 24 patients treated with the combined pharmacotherapy and hyperbaric oxygen therapy and group II – 16 patients treated only pharmacologically. The patients from Group 1 were treated in the Centre of Hyperbaric Therapy CREATOR Ltd. in Lodz, Poland. Each patient underwent 15 sessions in a hyperbaric chamber. In all patients, the percentage of hearing loss for the selected frequencies was assessed before and after the therapy according to Sabine and Fowler. Results: The group of 40 patie nts aged from 33 to 77 years (mean 52.4) included 21 females and 19 males. Group I consisted of 24 patients, 11 females and 13 males, group II consisted of 16 patients, 10 females, and 6 males. After therapy, the mean hearing level in all patients improved by 27.14%, in Group I – by 34.34%, in Group II – by 16.3%. Conclusions: Early hyperbaric oxygen therapy combined with steroid therapy improves prognosis and shows good results in sudden hearing loss treatment.

Przypisy

• 1. Arastou S., Tajedini A., Borghei P.: Combined intratympanic and systemicsteroid therapy for poor-prognosis sudden sensorineural hearingloss. Iran J. Otorhinolaryngol., 2013; 25: 23–28
  Google Scholar
• 2. Bravenboer de Sousa M., Cazemier S., Stegeman I., Thomeer H.: Useof vasodilators in idiopathic sudden sensorineural hearing loss: A systematicreview. J. Int. Adv. Otol., 2017; 13: 399–403
  Google Scholar
• 3. Ergun Tadöven G., Derin A.T., Yaprak N., Özçalar H.Ü.: The place ofhyperbaric oxygen therapy and ozone therapy in sudden hearing loss.Braz. J. Otorhinolaryngol., 2017; 83: 457–463
  Google Scholar
• 4. Gold Standard. Prednisone. In: Clinical Key. Atlanta, GA: Elsevier. c2015.https://www.clinicalkey.com/#!/content/drug_monograph/6-s2.0-505
  Google Scholar
• 5. Heuschkel A., Geißler K., Boeger D., Buentzel J., Esser D., HoffmannK., Jecker P., Mueller A., Radtke G., Guntinas-Lichius O.: Inpatient treatmentof patients with idiopathic sudden sensorineural hearing loss:A population-based healthcare research study. Eur. Arch. Otorhinolaryngol.,2018; 275: 699–707
  Google Scholar
• 6. Jadczak M., Rapiejko P., Kantor I., Szczygielski K., Usowski J., PiechockJ., Jurkiewicz D.: Evaluation of hyperbaric oxygen and pharmacologicaltherapy in sudden hearing loss. Otolaryngol. Pol., 2007; 61: 887–891
  Google Scholar
• 7. Kuhn M., Heman-Ackah S.E., Shaikh J.A., Roehm P.C.: Suddensensorineural hearing loss: A review of diagnosis, treatment, andprognosis. Trends Amplif., 2011; 15: 91–105
  Google Scholar
• 8. Labatut T., Daza M.J., Alonso A.: Intratympanic steroids as primaryinitial treatment of idiopathic sudden sensorineural hearing loss.The Hospital Universitario Ramón y Cajal experience and review ofthe literature. Eur. Arch. Otorhinolaryngol., 2013; 270: 2823–2832
  Google Scholar
• 9. Lai D., Zhao F., Jalal N., Zheng Y.: Intratympanic glucocorticosteroidtherapy for idiopathic sudden hearing loss: Meta-analysis ofrandomized controlled trials. Medicine, 2017; 96: e8955
  Google Scholar
• 10. Lamm H., Lamm K., Zimmermann W.: The effects of hyperbaricoxygen on experimental noise damage to the ears. Arch. Otorhinolaryngol.,1982; 236: 237–244
  Google Scholar
• 11. Marx M., Younes E., Chandrasekhar S.S., Ito J., Plontke S., O’LearyS., Sterkers O.: International consensus (ICON) on treatment ofsudden sensorineural hearing loss. Eur. Ann. Otorhinolaryngol. HeadNeck Dis., 2018; 135: S23–S28
  Google Scholar
• 12. McMonnies C.W.: Hyperbaric oxygen therapy and the possibilityof ocular complications or contraindications. Clin. Exp. Optom.,2015; 98: 122–125
  Google Scholar
• 13. Olex-Zarychta D.: Successful treatment of sudden sensorineuralhearing loss by means of pharmacotherapy combined with earlyhyperbaric oxygen therapy: Case report. Medicine, 2017; 96: e9397
  Google Scholar
• 14. Pezzoli M., Magnano M., Maffi L., Pezzoli L., Marcato P., OrioneM., Cupi D., Bongioannini G.: Hyperbaric oxygen therapy as salvage treatment for sudden sensorineural hearing loss: A prospectivecontrolled study. Eur. Arch. Otorhinolaryngol., 2015; 272: 1659–1666
  Google Scholar
• 15. Rossini B.A., de Oliveira Penido N., Munhoz M.S., Bogaz E.A., CuriR.S.: Sudden sensorioneural hearing loss and autoimmune systemicdiseases. Int. Arch. Otorhinolaryngol., 2017; 21: 213–223
  Google Scholar
• 16. Satar B., Hidir Y., Yetiser S.: Effectiveness of hyperbaric oxygentherapy in idiopathic sudden hearing loss. J. Laryngol. Otol., 2006;120: 665–669
  Google Scholar
• 17. Śliwińska-Kowalska M., Narożny W., Sekuła A., Pawlak-OsińskaK., Morawski K., Kot J., Kantor I., Karaszewski B., Konopka W.: Suddensensorineural hearing loss – position paper of the Polish Society ofAudiology and Phoniatrics on the diagnostic and therapeutic recommendations.Otorynolaryngoloigia, 2015; 14: 65–73
  Google Scholar
• 18. Stachler R.J., Chandrasekhar S.S., Archer S.M., Rosenfeld R.M.,Schwartz S.R., Barrs D.M., Brown S.R., Fife T.D., Ford P., Ganiats T.G.,Hollingsworth D.B., Lewandowski C.A., Montano J.J., Saunders J.E.,Tucci D.L., Valente M., et al.: Clinical practice guideline: sudden hearingloss. Otolaryngol. Head Neck Surg., 2012; 146: S1–S35
  Google Scholar
• 19. Topuz E., Yigit O., Cinar U., Seven H.: Should hyperbaric oxygenbe added to treatment in idiopathic sudden sensorineural hearingloss? Eur. Arch. Otorhinolaryngol., 2004; 261: 393–396
  Google Scholar
• 20. Tsounis M., Psillas G., Tsalighopoulos M., Vital V., MaroudiasN., Markou K.: Systemic, intratympanic and combined administrationof steroids for sudden hearing loss. A prospective randomizedmulticenter trial. Eur. Arch. Otorhinolaryngol., 2018;275: 103–110
  Google Scholar
• 21. Yang C.H., Wu R.W., Hwang C.F.: Comparison of intratympanicsteroid injection, hyperbaric oxygen and combination therapy inrefractory sudden sensorineural hearing loss. Otol. Neurotol., 2013;34: 1411–1416
  Google Scholar

Pełna treść artykułu